ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer

Authors

Tarah Jean Ballinger
Fengmin Zhao
Joseph A. Sparano
Sofia F. Garcia
Fei Shen
Shamsuddin Virani, Advocate Health - MidwestFollow

Recommended Citation

Ballinger TJ, Zhao F, Sparano JA, et al. ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer. Journal of Clinical Oncology. 2024;42(17_suppl):LBA503-LBA503. doi:10.1200/JCO.2024.42.17_suppl.LBA503

Affiliations

Aurora Cancer Care, Burlington

Document Type

Abstract